Pivotal bioVenture Partners Fund I, L.P. 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-27 5:42 pm Sale | 2025-07-01 | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 0 0.000% | -4,494,851 (Position Closed) | Filing |
| 2024-02-12 9:06 pm Unchanged | 2024-02-12 | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 4,494,851 7.200% | 0 (Unchanged) | Filing |
| 2023-08-07 9:58 pm Purchase | 2023-08-01 | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 4,494,851 9.500% | 833,333 (+22.76%) | Filing |
| 2023-05-23 4:48 pm Purchase | 2023-05-12 | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 3,661,518 8.300% | 447,932 (+13.94%) | Filing |
| 2023-04-04 08:59 am Purchase | 2023-03-29 | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 3,213,586 7.400% | 552,432 (+20.76%) | Filing |
| 2022-04-28 4:58 pm Purchase | 2022-04-19 | 13D | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 2,661,154 6.600% | 1,070,000 (+67.25%) | Filing |
| 2022-02-14 09:26 am Unchanged | 2021-12-31 | 13G | INOZYME PHARMA INC INZY | Pivotal bioVenture Partners Fund I, L.P. | 1,591,154 6.700% | 0 (Unchanged) | Filing |